Azeez Farooki
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Azeez Farooki as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:13 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06168812 · A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Ductal Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:13 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.Breast Cancer Res Treat · 2020128 citationsRCR 5.6
- A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.Gynecol Oncol · 201991 citationsRCR 3.3
- A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.Cancer · 202023 citationsRCR 0.8
- A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer.Breast Cancer Res · 202413 citationsRCR 1.4